These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9568995)

  • 1. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.
    Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    J Med Microbiol; 1998 Apr; 47(4):295-301. PubMed ID: 9568994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of passive immunotherapy on murine gut-derived sepsis caused by Pseudomonas aeruginosa.
    Matsumoto T; Furuya N; Tateda K; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    J Med Microbiol; 1999 Aug; 48(8):765-770. PubMed ID: 10451000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
    Homma JY; Tanimoto H
    Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
    [No Abstract]   [Full Text] [Related]  

  • 5. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
    Homma JY; Tanimoto H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
    Yamamoto M; Kubota Y; Matsuura M; Homma JY
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
    Yamamoto M; Kubota Y; Matsuura M; Homma JY
    Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.
    Pavlovskis OR; Edman DC; Leppla SH; Wretlind B; Lewis LR; Martin KE
    Infect Immun; 1981 May; 32(2):681-9. PubMed ID: 6788700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients.
    Trancassini M; De Vito D; Quattrucci S; Cipriani P
    New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
    Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
    BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A].
    Brodinova NS; Vovk VA; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa.
    Homma JY; Abe C; Tanamoto K; Hirao Y; Morihara K; Tsuzuki H; Yanagawa R; Honda E; Aoi Y; Fujimoto Y; Goryo M; Imazeki N; Noda H; Goda A; Takeuchi S; Ishihara T
    Jpn J Exp Med; 1978 Apr; 48(2):111-33. PubMed ID: 101698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model.
    Gilleland HE; Gilleland LB; Fowler MR
    J Med Microbiol; 1993 Feb; 38(2):79-86. PubMed ID: 8429543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of elastase, protease and common antigen (OEP) from Pseudomonas aeruginosa on protection against burns in mice.
    Kawaharajo K; Homma JY
    Jpn J Exp Med; 1977 Dec; 47(6):495-500. PubMed ID: 416253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization.
    Pollack M; Prescott RK
    J Infect Dis; 1982 May; 145(5):688-98. PubMed ID: 6804576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
    Jagger KS; Robinson DL; Franz MN; Warren RL
    J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
    Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F
    Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
    Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
    J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis.
    Granström M; Ericsson A; Strandvik B; Wretlind B; Pavlovskis OR; Berka R; Vasil ML
    Acta Paediatr Scand; 1984 Nov; 73(6):772-7. PubMed ID: 6441448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa].
    Steuhl KP; Döring G; Thiel HJ
    Fortschr Ophthalmol; 1989; 86(4):283-6. PubMed ID: 2507425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.